Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionHerold Advisors, Inc.
Latest Disclosed Ownership3,624 shares
Latest Disclosed Value $ 1,275,120
Herold Advisors, Inc. reports 1.28% decrease in ownership of AMGN / Amgen Inc.

On May 14, 2026 - Herold Advisors, Inc. filed a 13F-HR form disclosing ownership of 3,624 shares of Amgen Inc. (CH:AMGN) valued at $1,275,120 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 3,671 shares of Amgen Inc.. This represents a change in shares of -1.28% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMGEN COM 031162100 3,624 -47 -1.28 1,275 6.16 0.2800
2026-02-17 2025-12-31 13F AMGEN COM 031162100 3,671 193 5.55 1,201 22.43 0.2685
2025-11-13 2025-09-30 13F AMGEN COM 031162100 3,478 -263 -7.03 982 -6.03 0.2275
2025-08-14 2025-06-30 13F AMGEN COM 031162100 3,741 -244 -6.12 1,045 -15.87 0.2190
2025-05-13 2025-03-31 13F AMGEN COM 031162100 3,985 -1,016 -20.32 1,242 -4.76 0.2727
2025-02-14 2024-12-31 13F AMGEN COM 031162100 5,001 -296 -5.59 1,304 -23.62 0.2841
2024-11-14 2024-09-30 13F AMGEN COM 031162100 5,297 -7 -0.13 1,707 2.96 0.3706
2024-07-24 2024-06-30 13F AMGEN COM 031162100 5,304 393 8.00 1,657 18.70 0.3833
2024-05-10 2024-03-31 13F AMGEN COM 031162100 4,911 3,037 162.06 1,397 159.00 0.3378
2024-02-02 2023-12-31 13F AMGEN COM 031162100 1,874 -200 -9.64 540 -3.23 0.1494
2023-11-08 2023-09-30 13F AMGEN COM 031162100 2,074 707 51.72 557 83.83 0.1696
2023-07-17 2023-06-30 13F AMGEN COM 031162100 1,367 277 25.41 303 15.21 0.0929
2023-04-19 2023-03-31 13F AMGEN COM 031162100 1,090 320 41.56 263 30.20 0.0910
2023-02-14 2022-12-31 13F AMGEN COM 031162100 770 770 202 0.0857
2022-07-15 2022-06-30 13F AMGEN INC COM COM 031162100 0 -733 -100.00 0 -100.00
2022-05-09 2022-03-31 13F AMGEN INC COM COM 031162100 733 733 177,383 0.0631
2022-01-20 2021-12-31 13F AMGEN INC COM COM 031162100 0 -732 -100.00 0 -100.00
2021-11-03 2021-09-30 13F AMGEN INC COM COM 031162100 732 732 155 0.0603
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.